Last Close
Mar 19  •  05:07AM ET
10.70
Dollar change
0.00
Percentage change
0.00
%
Index- P/E38.23 EPS (ttm)0.28 Insider Own19.52% Shs Outstand19.78M Perf Week0.66%
Market Cap263.04M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.78M Perf Month0.22%
Enterprise Value261.72M PEG- EPS next Q- Inst Own74.52% Short Float0.25% Perf Quarter0.94%
Income6.88M P/S- EPS this Y- Inst Trans- Short Ratio1.08 Perf Half Y2.20%
Sales0.00M P/B1.36 EPS next Y- ROA6.82% Short Interest0.05M Perf YTD1.13%
Book/sh7.85 P/C197.77 EPS next 5Y- ROE7.13% 52W High10.85 -1.38% Perf Year5.73%
Cash/sh0.05 P/FCF- EPS past 3/5Y- - ROIC3.56% 52W Low10.04 6.57% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility0.10% 0.59% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.21 Sales Y/Y TTM- Profit Margin- RSI (14)55.17 Recom-
Dividend Gr. 3/5Y- - Current Ratio1.21 EPS Q/Q3909.52% SMA200.35% Beta-0.07 Target Price-
Payout0.00% Debt/Eq0.00 Sales Q/Q- SMA500.61% Rel Volume0.00 Prev Close10.70
Employees3 LT Debt/Eq0.00 Earnings- SMA2001.88% Avg Volume46.38K Price10.70
IPODec 16, 2024 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume8 Change0.00%
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.